News and Resources
The pieces of a Petersburg pharmaceuticals hub continue to fall into place.
Pharmaceutical Ingredients Maker Plans $25 million Expansion at its Petersburg Plant, Adding 156 New Jobs
A manufacturer of pharmaceutical ingredients in Petersburg is planning a $25 million expansion of its operations that is expected to add 156 new jobs.
Governor Northam Announces AMPAC Fine Chemicals to Expand Petersburg Operation with $25 Million Investment, Adding 156 New Jobs
Pharmaceutical manufacturer is a collaborator in new government-funded partnership to produce essential medications
Source: Bloomberg In Washington, just four miles from the U.S. Capitol, a children’s hospital is forced at times to call up nearby medical centers to see if they can spare the therapies needed for its young cancer patients. In Chicago, a drug called epinephrine, which...
Leading Children’s Hospitals and Phlow Corp. Form an Unprecedented Coalition to Deliver Essential Medicines to Address Pediatric Drug Shortages
RICHMOND, Va., March 18, 2021 – Phlow Corp., a U.S.-based, public benefit corporation committed to a bold mission of providing every American with access to affordable, high-quality essential medicines, today joins in announcing the launch of a groundbreaking...
Phlow Corp. and USP Announce Strategic Alliance Focused on Pharmaceutical Continuous Manufacturing to Increase Supply of Essential Medicines for U.S. Patients
Phlow and the United States Pharmacopeia have formed a strategic alliance to develop a new laboratory that will certify and validate Pharmaceutical Continuous Manufacturing processes resulting in affordable, high-quality, U.S.-manufactured essential medicines.
Phlow Corp. Closes $20 Million Series A Financing to Further Essential Medicines Research and Development Programs and Advanced Manufacturing Initiatives
This injection of additional strategic capital will further enhance Phlow’s mission to reimagine the end-to-end domestic production critical to U.S. healthcare.
Congresswoman Spanberger Tours Phlow Corp, Focuses on Strengthening Domestic Supply Chain & Bringing High-Paying Jobs to Central Virginia
Phlow demonstrates a 100% U.S.-based and fully integrated solution that will have an extraordinary impact on the lives of patients and families for decades to come.
Rosemary Gibson, author of “China Rx: Exposing the Risks of America’s Dependence on China for Medicine,” on why Medicare should require hospitals to buy American-made essential generic medications.
Advanced Pharmaceutical Manufacturing Campus in Central Virginia Will Create 186 New Jobs in City of Petersburg
A unique partnership between Civica Rx, Phlow, VCU’s Medicines for All Institute, and AMPAC Fine Chemicals to ensure every American will have access to essential medicines.